$ACR
ACRES Commercial Realty Corp. Stock $acr

$acr Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000095017023018834 Filed on May 08, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$23.62M	$21.06M	$22.68M
YoY Change	17.7%	-7.14%	78.62%
Cost Of Revenue	$34.33M	$33.15M	$16.59M
YoY Change	97.12%	99.82%	10.23%
Gross Profit	$21.73M	$19.29M	$9.241M
YoY Change	18.12%	108.69%	-24.56%
Gross Profit Margin	92.0%	91.58%	40.75%
Selling, General & Admin	$13.32M	$12.47M	$8.865M
YoY Change	8.58%	40.61%	87.82%
% of Gross Profit	61.29%	64.64%	95.93%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.312M	$1.371M	$3.508M
YoY Change	-29.31%	-60.92%	46.17%
% of Gross Profit	6.04%	7.11%	37.96%
Operating Expenses	$16.28M	$17.85M	$7.215M
YoY Change	24.76%	147.43%	-1322.88%
Operating Profit	$5.450M	$1.433M	$2.026M
YoY Change	1.93%	-29.27%	-84.22%
Interest Expense	$32.44M	$31.38M	$14.91M
YoY Change	106.05%	110.47%	8.62%
% of Operating Profit	595.27%	2189.46%	735.78%
Other Income/Expense, Net	$242.0K	$855.0K	$338.0K
YoY Change	38.29%	152.96%	-69.08%
Pretax Income	$5.692M	$2.288M	$2.364M
YoY Change	3.08%	-3.21%	-81.9%
Income Tax	$134.0K	-$5.000K	$280.0K
% Of Pretax Income	2.35%	-0.22%	11.84%
Net Earnings	$5.558M	$2.293M	$2.084M
YoY Change	0.65%	10.03%	-84.04%
Net Earnings / Revenue	23.53%	10.89%	9.19%
Basic Earnings Per Share	$0.10	-$0.28	-$0.30
Diluted Earnings Per Share	$0.10	-$0.28	-$0.30
COMMON SHARES
Basic Shares Outstanding	8.590M	8.685M	9.097M
Diluted Shares Outstanding	8.535M	8.500M	9.097M

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$57.11M	$87.31M	$79.56M
YoY Change	63.79%	9.74%	12.06%
Cash & Equivalents	$57.11M	$87.31M	$79.56M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$69.73M	$99.88M	$85.84M
YoY Change	65.89%	16.36%	9.49%
LONG-TERM ASSETS
Property, Plant & Equipment	$157.4M	$150.7M	$64.70M
YoY Change	-7.31%	132.96%	65.9%
Goodwill
YoY Change
Intangibles	$8.376M	$8.628M
YoY Change	-31.18%
Long-Term Investments	$1.548M	$1.602M	$1.548M
YoY Change	0.0%	3.49%	-92.66%
Other Assets	$76.82M	$74.32M	$23.39M
YoY Change	78.54%	217.72%	-45.48%
Total Long-Term Assets	$2.197B	$2.222B	$2.001B
YoY Change	-5.08%	11.01%	26.82%
TOTAL ASSETS
Total Short-Term Assets	$69.73M	$99.88M	$85.84M
Total Long-Term Assets	$2.197B	$2.222B	$2.001B
Total Assets	$2.267B	$2.322B	$2.087B
YoY Change	-3.81%	11.23%	26.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$15.60M	$13.44M	$8.182M
YoY Change	43.91%	64.29%	147.94%
Accrued Expenses	$51.17M	$48.60M	$6.112M
YoY Change	-2.3%	695.14%	3.59%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$70.43M	$65.98M	$18.22M
YoY Change	4.91%	262.16%	59.82%
LONG-TERM LIABILITIES
Long-Term Debt	$1.749B	$1.811B	$1.626B
YoY Change	-5.04%	11.35%	24.37%
Other Long-Term Liabilities	$3.025M	$3.025M	$0.00
YoY Change			-100.0%
Total Long-Term Liabilities	$1.752B	$1.814B	$1.626B
YoY Change	-4.87%	11.54%	24.22%
TOTAL LIABILITIES
Total Short-Term Liabilities	$70.43M	$65.98M	$18.22M
Total Long-Term Liabilities	$1.752B	$1.814B	$1.626B
Total Liabilities	$1.823B	$1.880B	$1.644B
YoY Change	-4.53%	14.31%	24.52%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$9.000K	$9.000K
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$434.6M	$433.8M	$442.7M
YoY Change
Total Liabilities & Shareholders Equity	$2.267B	$2.322B	$2.087B
YoY Change	-3.81%	11.23%	26.0%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	$5.558M	$2.293M	$2.084M
YoY Change	0.65%	10.03%	-84.04%
Depreciation, Depletion And Amortization	$1.312M	$1.371M	$3.508M
YoY Change	-29.31%	-60.92%	46.17%
Cash From Operating Activities	$15.36M	$9.107M	$1.554M
YoY Change	26.3%	486.04%	-83.62%
INVESTING ACTIVITIES
Capital Expenditures	$6.434M	$8.918M	-$9.000K
YoY Change	-58590.91%	-99188.89%
Acquisitions
YoY Change
Other Investing Activities	$10.12M	$78.89M	$662.0K
YoY Change	-104.07%	11816.77%	-98.65%
Cash From Investing Activities	$3.681M	$69.97M	$653.0K
YoY Change	-101.48%	10615.31%	-98.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$3.885M
YoY Change			-59.19%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-67.93M	-62.63M	-200.8M
YoY Change	-132.14%	-68.81%	1504.05%
NET CHANGE
Cash From Operating Activities	15.36M	9.107M	1.554M
Cash From Investing Activities	3.681M	69.97M	653.0K
Cash From Financing Activities	-67.93M	-62.63M	-200.8M
Net Change In Cash	-48.89M	16.44M	2.207M
YoY Change	95.11%	645.08%	-95.21%
FREE CASH FLOW
Cash From Operating Activities	$15.36M	$9.107M	$1.554M
Capital Expenditures	$6.434M	$8.918M	-$9.000K
Free Cash Flow	$8.928M	$189.0K	$1.563M
YoY Change	-26.66%	-87.91%	-83.52%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilities
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2023Q1	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilities
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilities
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	120968000
CY2023Q1	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilities
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001332551
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	1-32733
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	ACRES COMMERCIAL REALTY CORP.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-2287134
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	390 RXR Plaza
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Uniondale
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	11556
CY2023Q1	dei	City Area Code CityAreaCode	516
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	535-0015
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	8589629
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	87314000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	66232000
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	33940000
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	38579000
CY2023Q1	us-gaap	Interest Receivable InterestReceivable	12570000
CY2022Q4	us-gaap	Interest Receivable InterestReceivable	11969000
CY2023Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	1994790000
CY2022Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	2057590000
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	23899000
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	18803000
CY2023Q1	us-gaap	Notes Receivable Net NotesReceivableNet	1970891000
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	2038787000
CY2023Q1	acr	Principal Paydowns Receivable PrincipalPaydownsReceivable	54000
CY2023Q1	us-gaap	Due From Related Parties DueFromRelatedParties	11200000
CY2022Q4	us-gaap	Due From Related Parties DueFromRelatedParties	11275000
CY2023Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	1548000
CY2022Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	1548000
CY2023Q1	us-gaap	Real Estate Heldforsale RealEstateHeldforsale	40377000
CY2022Q4	us-gaap	Real Estate Heldforsale RealEstateHeldforsale	53769000
CY2023Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	130571000
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	20152000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	20281000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	441314000
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2321559000
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8628000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8880000
CY2023Q1	us-gaap	Other Assets OtherAssets	4314000
CY2022Q4	us-gaap	Other Assets OtherAssets	4364000
CY2023Q1	us-gaap	Assets Assets	2321559000
CY2022Q4	us-gaap	Assets Assets	2376652000
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	13442000
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	10391000
CY2023Q1	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	679000
CY2022Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	898000
CY2023Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	4762000
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	6921000
CY2023Q1	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	1810767000
CY2022Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	1867033000
CY2023Q1	acr	Lease Liabilities LeaseLiabilities	43837000
CY2022Q4	acr	Lease Liabilities LeaseLiabilities	43695000
CY2023Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	3262000
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	3262000
CY2022Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	113000
CY2023Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	3025000
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	3025000
CY2023Q1	us-gaap	Liabilities Liabilities	1879774000
CY2022Q4	us-gaap	Liabilities Liabilities	1935338000
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	41666666
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	41666666
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8646136
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8646136
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8708100
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8708100
CY2023Q1	acr	Common Stock Restricted Shares CommonStockRestrictedShares	583333
CY2022Q4	acr	Common Stock Restricted Shares CommonStockRestrictedShares	583333
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	9000
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	9000
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1174510000
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1174202000
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-6001000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-6394000
CY2023Q1	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	734775000
CY2022Q4	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	732359000
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	433753000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	435468000
CY2023Q1	us-gaap	Minority Interest MinorityInterest	8032000
CY2022Q4	us-gaap	Minority Interest MinorityInterest	5846000
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	441785000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2376652000
CY2023Q1	acr	Interest And Fee Income Loans Held In Portfolio InterestAndFeeIncomeLoansHeldInPortfolio	44470000
CY2022Q1	acr	Interest And Fee Income Loans Held In Portfolio InterestAndFeeIncomeLoansHeldInPortfolio	22657000
CY2023Q1	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	859000
CY2022Q1	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	19000
CY2023Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	45329000
CY2022Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	22676000
CY2023Q1	us-gaap	Interest Expense InterestExpense	31375000
CY2022Q1	us-gaap	Interest Expense InterestExpense	14907000
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	13954000
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	7769000
CY2023Q1	acr	Gross Profit Loss From Real Estate Operations GrossProfitLossFromRealEstateOperations	7071000
CY2022Q1	acr	Gross Profit Loss From Real Estate Operations GrossProfitLossFromRealEstateOperations	3138000
CY2023Q1	acr	Income Loss Dividend Income And Other Income Loss From Equity Method Investments IncomeLossDividendIncomeAndOtherIncomeLossFromEquityMethodInvestments	33000
CY2022Q1	acr	Income Loss Dividend Income And Other Income Loss From Equity Method Investments IncomeLossDividendIncomeAndOtherIncomeLossFromEquityMethodInvestments	16000
CY2023Q1	us-gaap	Revenues Revenues	21058000
CY2022Q1	us-gaap	Revenues Revenues	10923000
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2979000
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3457000
CY2023Q1	acr	Real Estate Expenses RealEstateExpenses	8860000
CY2022Q1	acr	Real Estate Expenses RealEstateExpenses	4794000
CY2023Q1	acr	Management Fees Related Party ManagementFeesRelatedParty	1773000
CY2022Q1	acr	Management Fees Related Party ManagementFeesRelatedParty	1682000
CY2023Q1	acr	Equity Compensation Related Party EquityCompensationRelatedParty	894000
CY2022Q1	acr	Equity Compensation Related Party EquityCompensationRelatedParty	744000
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	23000
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	22000
CY2023Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	5096000
CY2022Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-1802000
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	19625000
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	8897000
CY2023Q1	acr	Revenues Less Operating Expense RevenuesLessOperatingExpense	1433000
CY2022Q1	acr	Revenues Less Operating Expense RevenuesLessOperatingExpense	2026000
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-460000
CY2023Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	745000
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	110000
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	798000
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	855000
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	338000
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2288000
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2364000
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5000
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	280000
CY2023Q1	us-gaap	Profit Loss ProfitLoss	2293000
CY2022Q1	us-gaap	Profit Loss ProfitLoss	2084000
CY2023Q1	acr	Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders	4855000
CY2022Q1	acr	Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders	4855000
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-146000
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2416000
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2771000
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.30
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.30
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8500413
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9096977
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8500413
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9096977
CY2023Q1	us-gaap	Profit Loss ProfitLoss	2293000
CY2022Q1	us-gaap	Profit Loss ProfitLoss	2084000
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	-393000
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	-456000
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	393000
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	456000
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	2686000
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	2540000
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	-146000
CY2023Q1	acr	Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders	4855000
CY2022Q1	acr	Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders	4855000
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2023000
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2315000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	441314000
CY2023Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	756000
CY2023Q1	acr	Stock Issued During Period Value Share Based Compensation Adjustment To Additional Paid In Capital StockIssuedDuringPeriodValueShareBasedCompensationAdjustmentToAdditionalPaidInCapital	170000
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	894000
CY2023Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	2332000
CY2023Q1	us-gaap	Profit Loss ProfitLoss	2293000
CY2023Q1	acr	Distributions And Accrual Of Cumulative Preferred Stock Dividends DistributionsAndAccrualOfCumulativePreferredStockDividends	4855000
CY2023Q1	acr	Amortization Of Terminated Derivatives AmortizationOfTerminatedDerivatives	393000
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	441785000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	448195000
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	37000
CY2022Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	3885000
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	744000
CY2022Q1	us-gaap	Profit Loss ProfitLoss	2084000
CY2022Q1	acr	Distributions And Accrual Of Cumulative Preferred Stock Dividends DistributionsAndAccrualOfCumulativePreferredStockDividends	4855000
CY2022Q1	acr	Amortization Of Terminated Derivatives AmortizationOfTerminatedDerivatives	456000
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	442702000
CY2023Q1	us-gaap	Profit Loss ProfitLoss	2293000
CY2022Q1	us-gaap	Profit Loss ProfitLoss	2084000
CY2023Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	5096000
CY2022Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	-1802000
CY2023Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	1371000
CY2022Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	3508000
CY2023Q1	acr	Share Based Compensation Nonemployee And Directors ShareBasedCompensationNonemployeeAndDirectors	894000
CY2022Q1	acr	Share Based Compensation Nonemployee And Directors ShareBasedCompensationNonemployeeAndDirectors	744000
CY2022Q1	acr	Gains Losses On Extinguishment Of Debt Excluding Incurred On Cash Payments GainsLossesOnExtinguishmentOfDebtExcludingIncurredOnCashPayments	-460000
CY2023Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	745000
CY2023Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	-198000
CY2022Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	3440000
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9107000
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1554000
CY2023Q1	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	29559000
CY2022Q1	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	106768000
CY2023Q1	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	94064000
CY2022Q1	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	107192000
CY2023Q1	us-gaap	Payments For Proceeds From Real Estate Heldforinvestment PaymentsForProceedsFromRealEstateHeldforinvestment	8918000
CY2022Q1	us-gaap	Payments For Proceeds From Real Estate Heldforinvestment PaymentsForProceedsFromRealEstateHeldforinvestment	-188000
CY2023Q1	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate	14309000
CY2022Q1	us-gaap	Payments To Acquire Furniture And Fixtures PaymentsToAcquireFurnitureAndFixtures	9000
CY2023Q1	us-gaap	Proceeds From Collection Of Longterm Loans To Related Parties ProceedsFromCollectionOfLongtermLoansToRelatedParties	75000
CY2022Q1	us-gaap	Proceeds From Collection Of Longterm Loans To Related Parties ProceedsFromCollectionOfLongtermLoansToRelatedParties	50000
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	69971000
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	653000
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	756000
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3885000
CY2022Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	37000
CY2022Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	-37000
CY2022Q1	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	10150000
CY2023Q1	acr	Proceeds From Warehouse Financing Facilities And Repurchase Agreements ProceedsFromWarehouseFinancingFacilitiesAndRepurchaseAgreements	12095000
CY2022Q1	acr	Proceeds From Warehouse Financing Facilities And Repurchase Agreements ProceedsFromWarehouseFinancingFacilitiesAndRepurchaseAgreements	84992000
CY2022Q1	acr	Payments Of Commercial Real Estate Notes Payable PaymentsOfCommercialRealEstateNotesPayable	237189000
CY2023Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	38213000
CY2022Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	10150000
CY2023Q1	acr	Repayments Of Warehouse Financing Facilities And Repurchase Agreements RepaymentsOfWarehouseFinancingFacilitiesAndRepurchaseAgreements	29450000
CY2022Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	39839000
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	3787000
CY2022Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	30000
CY2023Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	2332000
CY2023Q1	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	4855000
CY2022Q1	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	4855000
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-62634000
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-200843000
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	16444000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-198636000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	104810000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	283931000
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	121254000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	85295000
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and within the period of financial results. Actual results could differ from those estimates. Estimates affecting the accompanying consolidated financial statements include, but are not limited to, the net realizable and fair values of the Company’s investments and derivatives, the estimated useful lives used to calculate depreciation, the expected lives over which to amortize premiums and accrete discounts, reversals of or provisions for expected credit losses and the disclosure of contingent liabilities.</span></p>
CY2023Q1	acr	Cash Balance In Excess Of Federal Deposit Insurance Limit Amount CashBalanceInExcessOfFederalDepositInsuranceLimitAmount	84100000
CY2022Q4	acr	Cash Balance In Excess Of Federal Deposit Insurance Limit Amount CashBalanceInExcessOfFederalDepositInsuranceLimitAmount	63300000
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	87314000
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	79561000
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	33940000
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	5734000
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	121254000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	85295000
CY2023Q1	acr	Investment In Real Estate Site Improvement Useful Life InvestmentInRealEstateSiteImprovementUsefulLife	P10Y
CY2023Q1	acr	Investment In Real Estate Tenant Improvements Useful Life Description InvestmentInRealEstateTenantImprovementsUsefulLifeDescription	Shorter of lease term or expected useful life
CY2023Q1	acr	Operating Loss Carryforwards Valuation Allowance Tax Expense Impact OperatingLossCarryforwardsValuationAllowanceTaxExpenseImpact	20800000
CY2023Q1	acr	Loans Receivable At Carrying Value LoansReceivableAtCarryingValue	2000000000.0
CY2023Q1	us-gaap	Change In Accounting Principle Accounting Standards Update Adopted ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted	true
CY2023Q1	us-gaap	Change In Accounting Principle Accounting Standards Update Adoption Date ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate	2023-03-31
CY2023Q1	us-gaap	Change In Accounting Principle Accounting Standards Update Immaterial Effect ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect	false
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	32028000
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	14894000
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	101000
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	180000
CY2023Q1	acr	Principal Paydowns Receivable PrincipalPaydownsReceivable	54000
CY2022Q4	acr	Principal Paydowns Receivable PrincipalPaydownsReceivable	0
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1200000
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1100000
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1000000.0
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1000000.0
CY2023Q1	acr	Non Acquired Operating Lease Right Of Use Asset NonAcquiredOperatingLeaseRightOfUseAsset	761000
CY2022Q4	acr	Non Acquired Operating Lease Right Of Use Asset NonAcquiredOperatingLeaseRightOfUseAsset	822000
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	803000
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	18803000
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	8805000
CY2023Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	5096000
CY2022	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	12295000
CY2022	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	2297000
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	23899000
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	18803000
CY2022Q1	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	21800000
CY2022Q1	acr	Percentage Of Total Amortization Cost PercentageOfTotalAmortizationCost	0.011
CY2023Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	5
CY2023Q1	us-gaap	Proceeds From Sale Of Property Held For Sale ProceedsFromSaleOfPropertyHeldForSale	15100000
CY2023Q1	acr	Selling Costs Of Property Held For Sale SellingCostsOfPropertyHeldForSale	845000
CY2023Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	745000
CY2023Q1	acr	Assets Acquired Cost AssetsAcquiredCost	205037000
CY2023Q1	acr	Assets Acquired Accumulated Depreciation And Amortization AssetsAcquiredAccumulatedDepreciationAndAmortization	6070000
CY2023Q1	acr	Assets Acquired AssetsAcquired	198967000
CY2022Q4	acr	Assets Acquired Cost AssetsAcquiredCost	208126000
CY2022Q4	acr	Assets Acquired Accumulated Depreciation And Amortization AssetsAcquiredAccumulatedDepreciationAndAmortization	5050000
CY2022Q4	acr	Assets Acquired AssetsAcquired	203076000
CY2023Q1	acr	Liabilities Assumed Cost LiabilitiesAssumedCost	64621000
CY2023Q1	acr	Liability Assumed Accumulated Depreciation And Amortization LiabilityAssumedAccumulatedDepreciationAndAmortization	211000
CY2023Q1	acr	Liabilities Assumed Book Value LiabilitiesAssumedBookValue	64410000
CY2022Q4	acr	Liabilities Assumed Cost LiabilitiesAssumedCost	64621000
CY2022Q4	acr	Liability Assumed Accumulated Depreciation And Amortization LiabilityAssumedAccumulatedDepreciationAndAmortization	421000
CY2022Q4	acr	Liabilities Assumed Book Value LiabilitiesAssumedBookValue	64200000
CY2023Q1	acr	Assets Acquired And Liabilities Assumed Cost AssetsAcquiredAndLiabilitiesAssumedCost	140416000
CY2023Q1	acr	Assets Acquired And Liabilities Assumed Net AssetsAcquiredAndLiabilitiesAssumedNet	134557000
CY2022Q4	acr	Assets Acquired And Liabilities Assumed Cost AssetsAcquiredAndLiabilitiesAssumedCost	143505000
CY2022Q4	acr	Assets Acquired And Liabilities Assumed Net AssetsAcquiredAndLiabilitiesAssumedNet	138876000
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	252000
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1200000
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1300000
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1829310000
CY2023Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	18543000
CY2023Q1	us-gaap	Notes Payable NotesPayable	1810767000
CY2023Q1	us-gaap	Longterm Debt Weighted Average Interest Rate LongtermDebtWeightedAverageInterestRate	0.0662
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	828000
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y6M
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y8M12D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0870
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0871
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	75000
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	24000
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	37000
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	23000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	115000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	155000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	159000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	163000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	167000
CY2023Q1	acr	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	303000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1062000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	259000
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	803000
CY2023Q1	acr	Debt Instrument Maturity Date Free Form DebtInstrumentMaturityDateFreeForm	P10Y3M18D
CY2023Q1	us-gaap	Collateral Already Posted Aggregate Fair Value CollateralAlreadyPostedAggregateFairValue	2089923000
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1884879000
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	17846000
CY2022Q4	us-gaap	Notes Payable NotesPayable	1867033000
CY2022Q4	us-gaap	Longterm Debt Weighted Average Interest Rate LongtermDebtWeightedAverageInterestRate	0.0629
CY2022	acr	Debt Instrument Maturity Date Free Form DebtInstrumentMaturityDateFreeForm	P10Y3M18D
CY2022Q4	us-gaap	Collateral Already Posted Aggregate Fair Value CollateralAlreadyPostedAggregateFairValue	2178430000
CY2023Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	377202000
CY2023Q1	us-gaap	Securities Loaned Fair Value Of Collateral SecuritiesLoanedFairValueOfCollateral	587280000
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	434422000
CY2022Q4	us-gaap	Securities Loaned Fair Value Of Collateral SecuritiesLoanedFairValueOfCollateral	675787000
CY2021Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0575
CY2021Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0575
CY2023Q1	us-gaap	Debt Instrument Redemption Description DebtInstrumentRedemptionDescription	100%
CY2021Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0575
CY2021Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0575
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	1829310000
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	313493000
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	18710000
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	150000000
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	53336000
CY2023Q1	acr	Long Term Debt Maturing In Year Four And After LongTermDebtMaturingInYearFourAndAfter	1293771000
CY2023Q1	acr	Common Shares Repurchased Cost CommonSharesRepurchasedCost	756000
CY2022Q1	acr	Common Shares Repurchased Cost CommonSharesRepurchasedCost	3900000
CY2023Q1	acr	Common Shares Repurchased CommonSharesRepurchased	79744
CY2022Q1	acr	Common Shares Repurchased CommonSharesRepurchased	314552
CY2023Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	894000
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	744000
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	9.45
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	9.45
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	14.22
CY2023Q1	acr	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected To Vest Remainder Of Fiscal Year ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestRemainderOfFiscalYear	166658
CY2023Q1	acr	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected To Vest Year One ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestYearOne	166658
CY2023Q1	acr	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected To Vest Year Two ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestYearTwo	166671
CY2023Q1	acr	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected To Vest Year Three ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestYearThree	83346
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	583333
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	3600000
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y8M12D
CY2023Q1	acr	Percentage Of Incentive Compensation Expense Payable In Cash PercentageOfIncentiveCompensationExpensePayableInCash	0.50
CY2023Q1	acr	Percentage Of Incentive Compensation Expense Payable In Common Stock PercentageOfIncentiveCompensationExpensePayableInCommonStock	0.50
CY2023Q1	us-gaap	Profit Loss ProfitLoss	2293000
CY2022Q1	us-gaap	Profit Loss ProfitLoss	2084000
CY2023Q1	acr	Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders	4855000
CY2022Q1	acr	Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders	4855000
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-146000
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2416000
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2771000
CY2023Q1	acr	Weighted Average Number Of Common Shares Outstanding Basic WeightedAverageNumberOfCommonSharesOutstandingBasic	8108418
CY2022Q1	acr	Weighted Average Number Of Common Shares Outstanding Basic WeightedAverageNumberOfCommonSharesOutstandingBasic	8630316
CY2023Q1	acr	Weighted Average Number Of Warrants Outstanding WeightedAverageNumberOfWarrantsOutstanding	391995
CY2022Q1	acr	Weighted Average Number Of Warrants Outstanding WeightedAverageNumberOfWarrantsOutstanding	466661
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8500413
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9096977
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8500413
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9096977
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.30
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.30
CY2023Q1	acr	Reit Required Taxable Income Distribution Percentage REITRequiredTaxableIncomeDistributionPercentage	0.90
CY2023Q1	acr	Reit Taxable Income Distribution For Exempt Federal Income Taxes Percentage REITTaxableIncomeDistributionForExemptFederalIncomeTaxesPercentage	1
CY2023Q1	acr	Derivative Instruments Amortization Expense Reported In Interest Expense DerivativeInstrumentsAmortizationExpenseReportedInInterestExpense	416000
CY2023Q1	us-gaap	Securities Sold Under Agreements To Repurchase Gross SecuritiesSoldUnderAgreementsToRepurchaseGross	311276000
CY2023Q1	us-gaap	Securities Sold Under Agreements To Repurchase Asset SecuritiesSoldUnderAgreementsToRepurchaseAsset	0
CY2023Q1	acr	Securities Sold Under Agreements To Repurchase Amount Not Offset Against Collateral SecuritiesSoldUnderAgreementsToRepurchaseAmountNotOffsetAgainstCollateral	311276000
CY2023Q1	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Securities SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities	311276000
CY2023Q1	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Cash SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash	0
CY2023Q1	us-gaap	Securities Sold Under Agreements To Repurchase Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election SecuritiesSoldUnderAgreementsToRepurchaseOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	0
CY2022Q4	us-gaap	Securities Sold Under Agreements To Repurchase Gross SecuritiesSoldUnderAgreementsToRepurchaseGross	328288000
CY2022Q4	us-gaap	Securities Sold Under Agreements To Repurchase Asset SecuritiesSoldUnderAgreementsToRepurchaseAsset	0
CY2022Q4	acr	Securities Sold Under Agreements To Repurchase Amount Not Offset Against Collateral SecuritiesSoldUnderAgreementsToRepurchaseAmountNotOffsetAgainstCollateral	328288000
CY2022Q4	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Securities SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities	328288000
CY2022Q4	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Cash SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash	0
CY2022Q4	us-gaap	Securities Sold Under Agreements To Repurchase Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election SecuritiesSoldUnderAgreementsToRepurchaseOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	0
CY2023Q1	us-gaap	Securities Sold Under Agreements To Repurchase Fair Value Of Collateral SecuritiesSoldUnderAgreementsToRepurchaseFairValueOfCollateral	434700000
CY2022Q4	us-gaap	Securities Sold Under Agreements To Repurchase Fair Value Of Collateral SecuritiesSoldUnderAgreementsToRepurchaseFairValueOfCollateral	453600000
CY2023Q1	us-gaap	Litigation Reserve LitigationReserve	0
CY2022Q4	us-gaap	Litigation Reserve LitigationReserve	0

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0000950170-23-018834-index-headers.html	Edgar Link	pending
0000950170-23-018834-index.html	Edgar Link	pending
0000950170-23-018834.txt	Edgar Link	pending
0000950170-23-018834-xbrl.zip	Edgar Link	pending
acr-20230331.htm	Edgar Link	pending
acr-20230331.xsd	Edgar Link	pending
acr-ex31_1.htm	Edgar Link	pending
acr-ex31_2.htm	Edgar Link	pending
acr-20230331_cal.xml	Edgar Link	unprocessable
acr-20230331_def.xml	Edgar Link	unprocessable
acr-20230331_lab.xml	Edgar Link	unprocessable
acr-20230331_pre.xml	Edgar Link	unprocessable
acr-20230331_htm.xml	Edgar Link	completed
acr-ex32_1.htm	Edgar Link	pending
acr-ex32_2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img81404349_0.jpg	Edgar Link	pending
img81404349_1.jpg	Edgar Link	pending
img81404349_2.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ACR
ACRES Commercial Realty Corp. Stock $acr

2023 Q2 Form 10-Q Financial Statement

#000095017023018834 Filed on May 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACR ACRES Commercial Realty Corp. Stock $acr

2023 Q2 Form 10-Q Financial Statement

#000095017023018834 Filed on May 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACR
ACRES Commercial Realty Corp. Stock $acr